Inflammatory and Analgesic Profiles in Intervertebral Disc Herniation: Variability with Respect to Neurological...

Area of Science:

• Biochemistry
• Immunology
• Neurology

Background:

• Lumbar disc herniation involves mechanical and biochemical processes leading to nerve compression, inflammation, and pain.
• Inflammatory processes in disc herniation vary by pain duration, type, and severity, but the link to neurological deficits is unclear.

Purpose of the Study:

• To compare serum levels of specific biomarkers in lumbar disc herniation patients with and without neurological deficits (WND/WOND) against healthy controls.
• Investigated biomarkers include TNF-α, IL-6, IL-4, IL-1β, beta-endorphin, anandamide, and 2-AG.

Main Methods:

• Serum samples were collected from 37 patients WND, 37 patients WOND, and 35 healthy individuals.
• Biomarker levels were quantified using commercial enzyme-linked immunosorbent assay (ELISA) kits.

Main Results:

• No significant difference in TNF-α levels was observed across all groups.
• Patients with lumbar disc herniation (WOND and WND) showed elevated IL-1β and IL-4 compared to controls.
• IL-6 levels were lower in the WND group than in controls; beta-endorphin, anandamide, and 2-AG levels did not differ significantly.

Conclusions:

• This study is the first to link neurological deficits in lumbar disc herniation to serum biomarker profiles.
• Changes in cytokine levels suggest potential regression of herniation, even with neurological deficits.
• Results highlight the need for novel treatment protocols targeting the inflammatory cascade in lumbar disc herniation.